Evidence map›Paper›PMID 41735786›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2026

Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010-2022.

Kristian Bolin, Karin Strandell, Andreas Palmborg, Sofie Gustafsson, Sven-Arne Silfverdal

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kristian BolinCentre for health Governance, Department of Economics, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0003-1682-295X
Karin StrandellDepartment of Clinical Sciences, Paediatrics, Umeå University, Umeå, Sweden.
Andreas PalmborgMedical and Scientific Affairs Vaccines, Pfizer AB, Stockholm, Sweden.
Sofie GustafssonDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden, Pfizer AB, Stockholm, Sweden.
Sven-Arne SilfverdalDepartment of Clinical Sciences, Paediatrics, Umeå University, Umeå, Sweden.ORCID 0000-0002-3606-3797

Funding

pfizer sweden
6 · The paper itself

Abstract

aimRespiratory syncytial virus (RSV) infection is a leading cause of paediatric hospitalisations. This study describes annual RSV-hospitalisation burden of disease, by gestational week of delivery, age and sex among children aged 0-17 years of age in Sweden, for the period 2010/11-2021/22.

methodsEmploying total population Swedish register data pertaining to hospitalisations due to RSV for the period 2010-2022.

resultsOver the study period a total of 26 772 children were hospitalised due to RSV. Most of the patients, 63.2%, were aged < 6 months and 39.9% were aged < 3 months. Among patients aged < 3 months, 88.5% were born at full term. The average number of hospital days increased with lower gestational age at birth for all age groups, except for patients aged 5- ≤ 17 years of age. Estimated incident rate ratios (IRR) comparing patients born at full term to patients born extremely preterm ranged between 2.43 and 1.75, respectively, for patients aged 0 < 3 months and 1 < 2 years of age.

conclusionsPaediatric RSV hospitalisations mostly occur in the youngest infants, and most are born at term. Gestational age at birth and age at admission are both negatively related to length of stay.

Indexed as

HospitalizationRespiratory Syncytial Virus InfectionsAdolescentChildChild, PreschoolFemaleGestational AgeHumansInfantInfant, NewbornMaleSwedengestational age at birthhospitalisationRSV

Identifiers

PMID41735786
PMCPMC13159787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.